MARKET

LEXX

LEXX

Lexaria Bioscience Corp
NASDAQ
2.880
-0.210
-6.80%
After Hours: 2.867 -0.013 -0.47% 19:30 10/02 EDT
OPEN
3.180
PREV CLOSE
3.090
HIGH
3.240
LOW
2.800
VOLUME
81.26K
TURNOVER
--
52 WEEK HIGH
21.60
52 WEEK LOW
2.800
MARKET CAP
4.76M
P/E (TTM)
-0.5456
1D
5D
1M
3M
1Y
5Y
1D
Lexaria Bioscience files to sell 923,827 shares of common stock for holders
TipRanks · 1d ago
Weekly Report: what happened at LEXX last week (0921-0925)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 09/24 21:05
Weekly Report: what happened at LEXX last week (0914-0918)?
Weekly Report · 09/21 09:07
Lexaria Extends Cash Runway Through 2027 After $7.9 Million Capital Boost
TipRanks · 09/18 02:02
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 09/17 21:06
Lexaria Bioscience updates financial position
TipRanks · 09/17 13:15
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 09/14 21:06
More
About LEXX
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXX stock methods without spending real money on the virtual paper trading platform.